Doxorubicin Global Strategic Research Report 2024: Market to Reach $1.7 Billion by 2030 from $1.1 Billion in 2023, Driven by Rise in Cancer Incidence and Innovations in Cancer Drug Delivery
April 05, 2024 09:07 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Doxorubicin Market to Reach $1.7...
Diffuse Large B-Cell Lymphoma Therapeutics Market Forecast to Reach $6.49 Billion by 2028 Amid Advancements in Personalized Medicine and Treatment Innovations
February 08, 2024 09:36 ET
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. As the global community...
Triple Negative Breast Cancer Market Analysis and Insights Reveal Dynamic Shifts and Future Growth Projections to 2032
January 24, 2024 10:36 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...
Global Thyroid Cancer Drugs Market Report 2024: Highlights Trends in Targeted Therapies, Featuring Profiles of Mylan Pharmaceuticals, AstraZeneca, Exelixis, Pfizer, and Bristol-Myers Squibb
January 23, 2024 15:28 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global thyroid cancer drugs market...
Global Thyroid Cancer Drugs Market to Reach $1.29 Billion by 2027: Targeted Therapies Transforming Thyroid Cancer Treatment
July 31, 2023 05:33 ET
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market Report 2023" has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive guide to...
Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001
May 24, 2023 04:00 ET
|
AKAMPION
- Addressing high unmet medical need in locally advanced soft tissue sarcoma- Targeted tumor treatment independent of specific molecular targets or tumor subtypes Munich, Germany – May 24,...
Global Thyroid Cancer Drugs Market Report 2023: Increasing Focus on Early Diagnosis and Treatment Drives Growth
May 09, 2023 07:49 ET
|
Research and Markets
Dublin, May 09, 2023 (GLOBE NEWSWIRE) -- The "Global Thyroid Cancer Drugs Market by Drug (Cabozantinib-S-Malate, Caprelsa, Cometriq), End User (Hospitals, Oncology Clinics, Research Organizations) -...
Global Ovarian Cancer Drugs Market Report 2023: Major Players Include AstraZeneca, Roche, Tesaro, Clovis Oncology and Amgen
April 14, 2023 10:28 ET
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Head and Neck Cancer Therapeutics Global Market 2022: Sector to Reach $3.5 Billion by 2030 with APAC Being the Fastest Growing Region
February 23, 2023 05:23 ET
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Head And Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy), By...
Outlook on the Liposomal Doxorubicin Global Market: Industry Analysis for 2015-2021 and Opportunity Assessment for 2022-2032
November 04, 2022 07:28 ET
|
Research and Markets
Dublin, Nov. 04, 2022 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market" report has been added to ResearchAndMarkets.com's offering.A recent market study published on Liposomal Doxorubicin...